Sort
15,842 grants matching “pancreatic cancer”
First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
$799,560Alexander B Sigalov · Signablok, Inc. · R44 · FY2019 · CA
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
$799,422Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2014 · CA
Immunotherapy for Malignant Mesothelioma
$798,901Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Development of a precision medicine platform for circadian based therapeutics in pancreatic cancer
$798,207Faraz Bishehsari · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · CA
Circulating Biomarker Consortium for Pancreatic Cancer Early Detection
$798,046Brian Matthew Wolpin · Dana-Farber Cancer Inst · U01 · FY2016 · CA
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT)
$797,939Bechien Wu · Kaiser Foundation Research Institute · R01 · FY2020 · CA
Prospective Trial of a Linguistically and Culturally Appropriate Mainstreaming Model for Hereditary Cancer Multigene Panel Testing Among Diverse Cancer Patients
$797,354Jada Gabrielle Hamilton · Sloan-Kettering Inst Can Research · U01 · FY2020 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$797,101Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses.
$796,798Evan Chen Lien · Van Andel Research Institute · U01 · FY2025 · CA
Diet-mediated regulation of fatty acid saturation impacts cancer progression and therapy responses.
$796,798Evan Chen Lien · Van Andel Research Institute · U01 · FY2024 · CA
Fibroblast Heterogeneity in Pancreatic Cancer
$796,363David Tuveson · Cold Spring Harbor Laboratory · R01 · FY2025 · CA
Novobiocin-mediated polymerase theta inhibition in homologous recombination repair-deficient cancers
$795,857Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
$795,401Charite Nicolette Ricker · University Of Southern California · R01 · FY2022 · CA
A Clinical Validation Center for Early Detection of Pancreatic Cancer
$794,418Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · CA
Circulating Biomarker Consortium for Pancreatic Cancer Early Detection
$794,139Brian Matthew Wolpin · Dana-Farber Cancer Inst · U01 · FY2017 · CA
Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions
$793,800Ying Yuan · University Of Tx Md Anderson Can Ctr · U24 · FY2023 · CA
LKB1 tumor suppressor and human cancer
$793,787Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2012 · CA
Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
$793,749Charite Nicolette Ricker · University Of Southern California · R01 · FY2025 · CA
A high sensitivity gamma camera using a combination of Compton reconstruction and source proximity for in-vivo imaging of Ac-225
$792,013Javier Caravaca · University Of California, San Francisco · R01 · FY2023 · EB
Study Of Factors That Induce Differentiation Of Pancreatic Precursor Cells
$791,832Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK
Genetic Epidemiology of Cancer
$791,544Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2018 · HG
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
$791,318Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)
$791,000Rachael Stolzenberg-Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors
$790,568Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Optical imaging of pancreas cancer organoids for drug development and personalized treatment
$790,207Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2020 · CA